However, reported HSCT outcomes for GATA2 deficiency should be interpreted with caution, since the proportion of MDS with high-risk features, such as monosomy 7, and severity of concomitant organ dysfunction can affect the outcomes. Here, GATA2 is linked to myelodysplastic syndrome.